from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3917c/parB

LFCtreatmentdescriptionclass of inhibitor

1.078

Amikacinug/mL Amikacintranslation

0.277

Cap5-10ug/mL Capreomycintranslation

0.541

Rox10-50 ug/mL Roxithromycintranslation

-0.187

SM2-5 ug/mL Streptomycintranslation

1.060

Tet5-10 ug/mL Tetracyclinetranslation

-0.851

Rif0.2-5ug/mL Rifampicintranscription

-0.683

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.801

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.046

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.181

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.602

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.586

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.488

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.420

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.541

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.603

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.530

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.339

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.500

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.242

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.795

KCN5-20 ug/mL Potassium cyaniderespiration

0.127

NaN30.2-2 mM Sodium aziderespiration

-0.056

Nigericin50 uM Nigericinrespiration

0.598

TRC10-150 ug/mL Triclosanrespiration

0.821

TRZ10-25 ug/mL Thioridazinerespiration

1.625

Valinomycin0.5-10 uM Valinomycinrespiration

-0.681

ZnSO42 mM ZnSO4respiration

-0.068

menadione6-10 ug/mL Menadionerespiration

-0.638

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.579

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.588

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.562

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.031

NRP_1Non-replicating persistence stage 1dosRassociated

-0.511

Amp0.2mg/mL AmpicillincellWall

-0.553

Cephalexin20-100 ug/mL CephalexincellWall

-0.481

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.612

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.930

EMB10-20 ug/mL EthambutolcellWall

-0.170

Eta12-40 ug/mL EthionamidecellWall

0.086

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.296

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.410

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.596

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.726

BZA0.12 mg/mL BenzamidearomaticAmides

1.600

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.635

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.726

H2O24 mM hydrogen peroxideDNAdamaging

-0.253

Levo10 ug/mL LevofloxacinDNAdamaging

-0.939

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.397

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.181

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.786

UVUV-irradiationDNAdamaging

-0.247

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.919

Antimycin12.5-50 ug/mL Antimycin A?

-0.868

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.735

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.777

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.390

PA8240.2-2 ug/mL PA-824?

1.090

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.162

Verapamil50 uM Verapamil?

-1.004

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.057

methoxatin10-20 ug/mL Methoxatin?